Global Exosome Diagnostics and Therapeutics Market Research Report 2025(Status and Outlook)

March 2025 | 170 pages | ID: GDA2C1BCBCF5EN
Bosson Research

Abstracts

Report Overview

Exosome diagnostics and therapeutics involve the study and application of exosomes, which are small extracellular vesicles secreted by cells that contain proteins, nucleic acids, and other molecules. These exosomes play a crucial role in intercellular communication and have garnered significant interest in the fields of diagnostics and therapeutics due to their ability to transfer biomolecules between cells. In diagnostics, exosomes can serve as biomarkers for various diseases, offering a non-invasive method for early detection and monitoring of conditions such as cancer, neurodegenerative disorders, and infectious diseases. In therapeutics, exosomes have shown potential as drug delivery vehicles, enabling targeted delivery of therapeutic agents to specific cells or tissues. Additionally, exosomes themselves can exhibit therapeutic properties, such as immune modulation and tissue regeneration.

The market for exosome diagnostics and therapeutics is experiencing rapid growth driven by several key factors. One of the primary market drivers is the increasing prevalence of chronic and infectious diseases, creating a growing demand for non-invasive diagnostic tools with high sensitivity and specificity. Exosomes offer a promising solution in this regard, as they can provide valuable insights into disease progression and treatment response. Moreover, the rising interest in precision medicine and personalized healthcare is fueling the development of exosome-based diagnostics and therapeutics tailored to individual patients. Additionally, advancements in exosome isolation and characterization technologies are expanding the possibilities for research and clinical applications, driving further market growth. Overall, the exosome diagnostics and therapeutics market is poised for continued expansion as research efforts and investment in this field continue to grow.

This report provides a deep insight into the global Exosome Diagnostics and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Exosome Diagnostics and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Exosome Diagnostics and Therapeutics market in any manner.

Global Exosome Diagnostics and Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Aethlon Medical(US)

Exosome Diagnostics(US)

NanoSomix Inc.(US)

Thermo Fisher Scientific (US)

Malvern Instruments (UK)

System Biosciences(US)

NX Pharmagen (US)

Sistemic Inc(UK)

Capricor Therapeutics (US)

Exiqon A/S (Denmark)

Market Segmentation (by Type)

Instrument

Reagent

Software

Market Segmentation (by Application)

Diagnostic

Therapeutic

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Exosome Diagnostics and Therapeutics Market
• Overview of the regional outlook of the Exosome Diagnostics and Therapeutics Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Exosome Diagnostics and Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Exosome Diagnostics and Therapeutics
1.2 Key Market Segments
  1.2.1 Exosome Diagnostics and Therapeutics Segment by Type
  1.2.2 Exosome Diagnostics and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Exosome Diagnostics and Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Exosome Diagnostics and Therapeutics Product Life Cycle
3.3 Global Exosome Diagnostics and Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Exosome Diagnostics and Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Exosome Diagnostics and Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Exosome Diagnostics and Therapeutics Market Competitive Situation and Trends
  3.8.1 Exosome Diagnostics and Therapeutics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Exosome Diagnostics and Therapeutics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 EXOSOME DIAGNOSTICS AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS

4.1 Exosome Diagnostics and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Exosome Diagnostics and Therapeutics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Exosome Diagnostics and Therapeutics Market
5.7 ESG Ratings of Leading Companies

6 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Exosome Diagnostics and Therapeutics Price by Type (2020-2025)

7 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Exosome Diagnostics and Therapeutics Market Sales by Application (2020-2025)
7.3 Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)

8 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SALES BY REGION

8.1 Global Exosome Diagnostics and Therapeutics Sales by Region
  8.1.1 Global Exosome Diagnostics and Therapeutics Sales by Region
  8.1.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Region
8.2 Global Exosome Diagnostics and Therapeutics Market Size by Region
  8.2.1 Global Exosome Diagnostics and Therapeutics Market Size by Region
  8.2.2 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Region
8.3 North America
  8.3.1 North America Exosome Diagnostics and Therapeutics Sales by Country
  8.3.2 North America Exosome Diagnostics and Therapeutics Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Exosome Diagnostics and Therapeutics Sales by Country
  8.4.2 Europe Exosome Diagnostics and Therapeutics Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region
  8.5.2 Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Exosome Diagnostics and Therapeutics Sales by Country
  8.6.2 South America Exosome Diagnostics and Therapeutics Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region
  8.7.2 Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET PRODUCTION BY REGION

9.1 Global Production of Exosome Diagnostics and Therapeutics by Region(2020-2025)
9.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Exosome Diagnostics and Therapeutics Production
  9.4.1 North America Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
  9.4.2 North America Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Exosome Diagnostics and Therapeutics Production
  9.5.1 Europe Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
  9.5.2 Europe Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Exosome Diagnostics and Therapeutics Production (2020-2025)
  9.6.1 Japan Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
  9.6.2 Japan Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Exosome Diagnostics and Therapeutics Production (2020-2025)
  9.7.1 China Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
  9.7.2 China Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Aethlon Medical(US)
  10.1.1 Aethlon Medical(US) Basic Information
  10.1.2 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
  10.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Market Performance
  10.1.4 Aethlon Medical(US) Business Overview
  10.1.5 Aethlon Medical(US) SWOT Analysis
  10.1.6 Aethlon Medical(US) Recent Developments
10.2 Exosome Diagnostics(US)
  10.2.1 Exosome Diagnostics(US) Basic Information
  10.2.2 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
  10.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Market Performance
  10.2.4 Exosome Diagnostics(US) Business Overview
  10.2.5 Exosome Diagnostics(US) SWOT Analysis
  10.2.6 Exosome Diagnostics(US) Recent Developments
10.3 NanoSomix Inc.(US)
  10.3.1 NanoSomix Inc.(US) Basic Information
  10.3.2 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
  10.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Market Performance
  10.3.4 NanoSomix Inc.(US) Business Overview
  10.3.5 NanoSomix Inc.(US) SWOT Analysis
  10.3.6 NanoSomix Inc.(US) Recent Developments
10.4 Thermo Fisher Scientific (US)
  10.4.1 Thermo Fisher Scientific (US) Basic Information
  10.4.2 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
  10.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Market Performance
  10.4.4 Thermo Fisher Scientific (US) Business Overview
  10.4.5 Thermo Fisher Scientific (US) Recent Developments
10.5 Malvern Instruments (UK)
  10.5.1 Malvern Instruments (UK) Basic Information
  10.5.2 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
  10.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Market Performance
  10.5.4 Malvern Instruments (UK) Business Overview
  10.5.5 Malvern Instruments (UK) Recent Developments
10.6 System Biosciences(US)
  10.6.1 System Biosciences(US) Basic Information
  10.6.2 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
  10.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Market Performance
  10.6.4 System Biosciences(US) Business Overview
  10.6.5 System Biosciences(US) Recent Developments
10.7 NX Pharmagen (US)
  10.7.1 NX Pharmagen (US) Basic Information
  10.7.2 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
  10.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Market Performance
  10.7.4 NX Pharmagen (US) Business Overview
  10.7.5 NX Pharmagen (US) Recent Developments
10.8 Sistemic Inc(UK)
  10.8.1 Sistemic Inc(UK) Basic Information
  10.8.2 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
  10.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Market Performance
  10.8.4 Sistemic Inc(UK) Business Overview
  10.8.5 Sistemic Inc(UK) Recent Developments
10.9 Capricor Therapeutics (US)
  10.9.1 Capricor Therapeutics (US) Basic Information
  10.9.2 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
  10.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Market Performance
  10.9.4 Capricor Therapeutics (US) Business Overview
  10.9.5 Capricor Therapeutics (US) Recent Developments
10.10 Exiqon A/S (Denmark)
  10.10.1 Exiqon A/S (Denmark) Basic Information
  10.10.2 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
  10.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Market Performance
  10.10.4 Exiqon A/S (Denmark) Business Overview
  10.10.5 Exiqon A/S (Denmark) Recent Developments

11 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST BY REGION

11.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast
11.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country
  11.2.3 Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region
  11.2.4 South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Exosome Diagnostics and Therapeutics by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Exosome Diagnostics and Therapeutics by Type (2026-2033)
  12.1.2 Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Exosome Diagnostics and Therapeutics by Type (2026-2033)
12.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Application (2026-2033)
  12.2.1 Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application
  12.2.2 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Exosome Diagnostics and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Exosome Diagnostics and Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Exosome Diagnostics and Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2024)
Table 10. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Exosome Diagnostics and Therapeutics Manufacturing Sites and Area Served
Table 12. Manufacturers Exosome Diagnostics and Therapeutics Product Type
Table 13. Global Exosome Diagnostics and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Exosome Diagnostics and Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Exosome Diagnostics and Therapeutics Sales by Type (K Units)
Table 25. Global Exosome Diagnostics and Therapeutics Market Size by Type (M USD)
Table 26. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Type (2020-2025)
Table 27. Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2020-2025)
Table 28. Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Type (2020-2025)
Table 29. Global Exosome Diagnostics and Therapeutics Market Size Share by Type (2020-2025)
Table 30. Global Exosome Diagnostics and Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 31. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Application
Table 32. Global Exosome Diagnostics and Therapeutics Market Size by Application
Table 33. Global Exosome Diagnostics and Therapeutics Sales by Application (2020-2025) & (K Units)
Table 34. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2020-2025)
Table 35. Global Exosome Diagnostics and Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 36. Global Exosome Diagnostics and Therapeutics Market Share by Application (2020-2025)
Table 37. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
Table 38. Global Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 39. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2020-2025)
Table 40. Global Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 41. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2020-2025)
Table 42. North America Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 43. North America Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 48. South America Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 49. South America Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 52. Global Exosome Diagnostics and Therapeutics Production (K Units) by Region(2020-2025)
Table 53. Global Exosome Diagnostics and Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2020-2025)
Table 55. Global Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Aethlon Medical(US) Basic Information
Table 61. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
Table 62. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Aethlon Medical(US) Business Overview
Table 64. Aethlon Medical(US) SWOT Analysis
Table 65. Aethlon Medical(US) Recent Developments
Table 66. Exosome Diagnostics(US) Basic Information
Table 67. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
Table 68. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Exosome Diagnostics(US) Business Overview
Table 70. Exosome Diagnostics(US) SWOT Analysis
Table 71. Exosome Diagnostics(US) Recent Developments
Table 72. NanoSomix Inc.(US) Basic Information
Table 73. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
Table 74. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. NanoSomix Inc.(US) Business Overview
Table 76. NanoSomix Inc.(US) SWOT Analysis
Table 77. NanoSomix Inc.(US) Recent Developments
Table 78. Thermo Fisher Scientific (US) Basic Information
Table 79. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
Table 80. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Thermo Fisher Scientific (US) Business Overview
Table 82. Thermo Fisher Scientific (US) Recent Developments
Table 83. Malvern Instruments (UK) Basic Information
Table 84. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
Table 85. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Malvern Instruments (UK) Business Overview
Table 87. Malvern Instruments (UK) Recent Developments
Table 88. System Biosciences(US) Basic Information
Table 89. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
Table 90. System Biosciences(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. System Biosciences(US) Business Overview
Table 92. System Biosciences(US) Recent Developments
Table 93. NX Pharmagen (US) Basic Information
Table 94. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
Table 95. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. NX Pharmagen (US) Business Overview
Table 97. NX Pharmagen (US) Recent Developments
Table 98. Sistemic Inc(UK) Basic Information
Table 99. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
Table 100. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Sistemic Inc(UK) Business Overview
Table 102. Sistemic Inc(UK) Recent Developments
Table 103. Capricor Therapeutics (US) Basic Information
Table 104. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
Table 105. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Capricor Therapeutics (US) Business Overview
Table 107. Capricor Therapeutics (US) Recent Developments
Table 108. Exiqon A/S (Denmark) Basic Information
Table 109. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
Table 110. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Exiqon A/S (Denmark) Business Overview
Table 112. Exiqon A/S (Denmark) Recent Developments
Table 113. Global Exosome Diagnostics and Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 114. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 115. North America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 116. North America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 117. Europe Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 118. Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 119. Asia Pacific Exosome Diagnostics and Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 120. Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. South America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 122. South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 124. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Global Exosome Diagnostics and Therapeutics Sales Forecast by Type (2026-2033) & (K Units)
Table 126. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 127. Global Exosome Diagnostics and Therapeutics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 128. Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application (2026-2033)
Table 129. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Exosome Diagnostics and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Exosome Diagnostics and Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Exosome Diagnostics and Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Exosome Diagnostics and Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Exosome Diagnostics and Therapeutics Product Life Cycle
Figure 13. Exosome Diagnostics and Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Exosome Diagnostics and Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Exosome Diagnostics and Therapeutics
Figure 19. Global Exosome Diagnostics and Therapeutics Market PEST Analysis
Figure 20. Global Exosome Diagnostics and Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Exosome Diagnostics and Therapeutics Market Share by Type
Figure 27. Sales Market Share of Exosome Diagnostics and Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Exosome Diagnostics and Therapeutics by Type in 2024
Figure 29. Market Size Share of Exosome Diagnostics and Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Exosome Diagnostics and Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Exosome Diagnostics and Therapeutics Market Share by Application
Figure 33. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Exosome Diagnostics and Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Exosome Diagnostics and Therapeutics Market Share by Application in 2024
Figure 37. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Exosome Diagnostics and Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Exosome Diagnostics and Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Exosome Diagnostics and Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Exosome Diagnostics and Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Exosome Diagnostics and Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Exosome Diagnostics and Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Exosome Diagnostics and Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Exosome Diagnostics and Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Exosome Diagnostics and Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Exosome Diagnostics and Therapeutics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Exosome Diagnostics and Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Exosome Diagnostics and Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Application (2026-2033)